TP
STDY

Truvvo Partners’s SteadyMed Ltd STDY Stock Holding History

Truvvo Partners’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-373,369
Closed -$1.68M – 52
2018
Q2 		$1.68M Hold
373,369
– – 1.11% 12
2018
Q1 		$1.21M Hold
373,369
– – 0.45% 51
2017
Q4 		$1.38M Hold
373,369
– – 0.47% 48
2017
Q3 		$1.25M Hold
373,369
– – 0.42% 51
2017
Q2 		$2.35M Hold
373,369
– – 0.85% 33
2017
Q1 		$2.17M Hold
373,369
– – 0.97% 24
2016
Q4 		$971 Hold
373,369
– – 0.34% 55
2016
Q3 		$1.34M Hold
373,369
– – 0.6% 40
2016
Q2 		$1.22M Hold
373,369
– – 0.63% 39
2016
Q1 		$918K Hold
373,369
– – 0.41% 41
2015
Q4 		$1.22M Buy
+373,369
New +$1.12M 0.64% 33

Other funds holding STDY

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.43B AUM 22.6% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $1.89B AUM 33.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Truvvo Partners's STDY Position: Q3 2018 in Review

Truvvo Partners sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 373,369 shares — an estimated $1.68M sold.

Truvvo Partners first reported a position in STDY in Q4 2015 and held it in 11 quarters. The position peaked at $2.35M in Q2 2017. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

  • Truvvo Partners reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
  • Truvvo Partners sold 373,369 SteadyMed Ltd shares in Q3 2018, an estimated $1.68M.
  • Truvvo Partners first reported a position in SteadyMed Ltd in Q4 2015 and held it in 11 quarters.
  • Truvvo Partners's SteadyMed Ltd position peaked at $2.35M in Q2 2017.
  • 5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Truvvo Partners's 13F filing for Q3 2018, filed 14 Nov 2018.